Ribozyme's potential in cervical cancer control.
Britto
Ramona
R
Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India.
Somasundaram
Kumaravel
K
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis; D005260:Female; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D016337:RNA, Catalytic / Q000494:pharmacology*; D011878:Radiotherapy; D012097:Repressor Proteins / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
D000970:Antineoplastic Agents; C068651:E6 protein, Human papillomavirus type 16; D009856:Oncogene Proteins, Viral; D016337:RNA, Catalytic; D012097:Repressor Proteins; C427204:hammerhead ribozyme; D011505:Protein-Tyrosine Kinases